Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients
Abstract Neoplasm development in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) has been widely discussed. The aim of this work is to determine neoplasm frequency, relationship with the prescription pattern of DMTs, and influence of the patients’ baseline characteri...
Guardado en:
Autores principales: | Rosalía Gil-Bernal, Juan Luis González-Caballero, Raúl Espinosa-Rosso, Carmen Gómez-Gómez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e0434f4136d47b6b5db10f717e47481 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The importance of organic carbon as a coadjutant in the transport of pollutants
por: Juliana Pisa Grudzien Iubel, et al.
Publicado: (2021) -
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: Fabricio González-Andrade, et al.
Publicado: (2010) -
Emerging therapies for treatment of multiple sclerosis
por: John R Corboy, et al.
Publicado: (2010) -
OPPORTUNITIES OF ANTI B-CELL THERAPY IN MULTIPLE SCLEROSIS
por: E. P. Evdoshenko, et al.
Publicado: (2014) -
Vestibular Evoked Myogenic Potential in Multiple Sclerosis (MS)
por: Alaa Ameen Hamed, et al.
Publicado: (2020)